Business to Business (B2B) " >Business to Business (B2B)

Sandoz is committed to pioneering novel approaches to help people around the world access high-quality medicine. In line with this goal, Sandoz partners with select pharmaceutical companies to provide access to finished products and active ingredients manufactured across the global Novartis Technical Operations network.

Our customers have access to a broad portfolio of products and API’s manufactured to Novartis standards from an extensive range of therapeutic areas and drug delivery mechanisms.

In addition to high-quality finished products and raw materials, partners are offered operational and technical support to achieve a reliable and easily integrated supply service.

If you would like to discuss partnering opportunities, you can get in touch with us at various industry events.

Biotech Cooperations " >Biotech Cooperations

Sandoz is a world leading manufacturer of biotechnological products. Our expertise stems from decades of experience in this complex field, particularly in the production of intermediates for third parties. Early successes were marked by the production of the first-ever oral penicillin in 1951 (anti-infectives), and one of the first recombinant proteins, an interferon, in 1980 (biopharmaceuticals).

Over the years, our role has evolved from simply a contract manufacturer to a full-service provider, i.e. providing solutions for all steps in the value chain of a project through to building strong relationships with our partners. Underlying this role is trust – trust in the shared values of a global company, trust in the innovative solutions we provide, and trust in the quality of our products and services on the back of our long history and industry know-how.

Sandoz has traditionally been among the leading specialists in microbial fermentation of classic and recombinant microorganisms. Our comprehensive know-how is based on several decades of experience in the fields of classical microbial products and recombinant microbial production at a commercial scale. In 2004, we successfully extended our production technology into the field of mammalian cell culture.

Today, we are a fully integrated manufacturer of recombinant products. We provide customized solutions for our partners that span the entire value chain, from development to production and fill and finish to customers. The flexibility in production capabilities to fully integrated services offers a variety of options when it comes to scaling different phases of development and commercial manufacturing, furthering the cost advantage to customers.

Sandoz is currently engaged in biotech cooperations with a number of leading organizations and continuously looks to extend its number of partnerships in the future. This strong experience combined with a successful track record of accomplishments and state-of-the-art plants, offers a unique opportunity to partners interested in pursuing manufacturing cooperations.


For additional information, please contact:

Contact Biotech Cooperations

Wolfgang Walcher
Head Biotech Cooperations
Phone: +43 (0)5338 200 3852
[email protected]

Sandoz GmbH

Biochemiestrasse 10
A-6250 Kundl
Austria